Awards
Following a call for proposals in 2007/2008, awards have been made to nine studies in June 2008. The principal investigators of the awards are:
Dr Robert J O Davies, Churchill Hospital, Oxford
Adjuvant Urokinase in the Treatment of Malignant Pleural Effusion: The Third Therapeutic Intervention in Malignant Pleural Effusion Trial (TIME3-UK)
Professor Nora Kearney, University of Stirling
Improving the symptom experience of patients with lung cancer receiving radiotherapy: Advance Symptom Management System for Radiotherapy (ASyMS-R)
Dr Matthew K Makin, The Marie Curie Palliative Care Institute Liverpool
The role of cordotomy in the management of mesothelioma-related pain in the United Kingdom (The INPIC Pilot study) (Invasive Procedures In Cancer Pain)
Professor Alex Molassiotis, University of Manchester
A non-pharmacological supportive care intervention for patients with lung cancer and their caregivers in the management of the respiratory distress symptom cluster.
Dr Mary O’Brien, The Royal Marsden NHS Foundation Trust, London
Randomised Evaluation of STents to Open REstricted AIRways in patients with centrally placed non-small cell lung cancer (RESTORE – AIR)
Dr Neil Steven, CR_UK Clinical Trials Unit, University of Birmingham
Improving the management of cachexia in patients with advanced lung cancer. Does the introduction of a structured nutritional support programme and/ or beta-hydroxy beta-methylbutyrate supplementation improve nutritional status and quality of life?
Dr Bee Wee, Nuffield Department of Medicine, Oxford
Modafinil for the treatment of fatigue in lung cancer: a multicentre, randomised, double-blinded, placebo-controlled trial
Professor David Weller, University of Edinburgh
What is the optimal role for primary care in the management and follow-up of patients with lung cancer?
Dr Andrew Wilcock, University of Nottingham
Is neuromuscular electrical stimulation an acceptable and feasible supportive therapy for patients with non-small cell lung cancer receiving palliative chemotherapy?
Marie Curie Cancer Care, which has managed the call and the selection process, will continue to administer the awards on behalf of the funding partners.
Information about this initiative can be obtained from:
Dr Teresa Tate, the Medical Adviser of Marie Curie Cancer Care
Tel: 020 7599 7252,
E-mail: teresa.tate@mariecurie.org.uk (quoting ‘NCRI Lung Cancer SuPaC Research Award’); or
Dr Gek Kwan-Lim, the Project Manager of the Research Collaborative
Tel: 020 7599 7246
E-mail: gek.kwan-lim@mariecurie.org.uk (quoting ‘NCRI Lung Cancer SuPaC Research Award’)
